Search research articles
Contact Us
Filters
Showing results (41-50 of 101) with videos related to
Page
of 11
Sort By:
Oncotarget
|
January 2, 2018
WEE1 epigenetically modulates 5-hmC levels by pY37-H2B dependent regulation of <i>IDH2</i> gene expression
Nupam P Mahajan, Pavani Malla, Shambhavi Bhagwat, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2020
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells
Patrick Innamarato, Sarah Asby, Jennifer Morse, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2021
Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma
Rana Falahat, Anders Berglund, Ryan M Putney, et al.
Cancer Immunology, Immunotherapy : CII
|
June 20, 2020
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model
Brittany L Bunch, Krithika N Kodumudi, Ellen Scott, et al.
Frontiers in Immunology
|
March 15, 2021
The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
Ahmet Murat Aydin, Brittany L Bunch, Matthew Beatty, et al.
Plos One
|
January 29, 2015
Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis
Nadine Nelson, Shengyan Xiang, Xiaohong Zhang, et al.
Plos One
|
April 6, 2013
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy
Jessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, et al.
Radiation Oncology (London, England)
|
September 13, 2024
Spatially fractionated GRID radiation potentiates immune-mediated tumor control
Rebecca A Bekker, Nina Obertopp, Gage Redler, et al.
Journal for Immunotherapy of Cancer
|
December 11, 2020
Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo
Brittany L Bunch, Jennifer Morse, Sarah Asby, et al.
Nature Communications
|
March 23, 2023
Epigenetic state determines the in vivo efficacy of STING agonist therapy
Rana Falahat, Anders Berglund, Patricio Perez-Villarroel, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 101) with videos related to
Sort By:
Page
of 11
Oncotarget
|
January 2, 2018
WEE1 epigenetically modulates 5-hmC levels by pY37-H2B dependent regulation of <i>IDH2</i> gene expression
Nupam P Mahajan, Pavani Malla, Shambhavi Bhagwat, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2020
Intratumoral Activation of 41BB Costimulatory Signals Enhances CD8 T Cell Expansion and Modulates Tumor-Infiltrating Myeloid Cells
Patrick Innamarato, Sarah Asby, Jennifer Morse, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 8, 2021
Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma
Rana Falahat, Anders Berglund, Ryan M Putney, et al.
Cancer Immunology, Immunotherapy : CII
|
June 20, 2020
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model
Brittany L Bunch, Krithika N Kodumudi, Ellen Scott, et al.
Frontiers in Immunology
|
March 15, 2021
The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications
Ahmet Murat Aydin, Brittany L Bunch, Matthew Beatty, et al.
Plos One
|
January 29, 2015
Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis
Nadine Nelson, Shengyan Xiang, Xiaohong Zhang, et al.
Plos One
|
April 6, 2013
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy
Jessica Ann Chacon, Richard C Wu, Pariya Sukhumalchandra, et al.
Radiation Oncology (London, England)
|
September 13, 2024
Spatially fractionated GRID radiation potentiates immune-mediated tumor control
Rebecca A Bekker, Nina Obertopp, Gage Redler, et al.
Journal for Immunotherapy of Cancer
|
December 11, 2020
Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo
Brittany L Bunch, Jennifer Morse, Sarah Asby, et al.
Nature Communications
|
March 23, 2023
Epigenetic state determines the in vivo efficacy of STING agonist therapy
Rana Falahat, Anders Berglund, Patricio Perez-Villarroel, et al.
Page
of 11